John F. Sheridan
2021
Compensation breakdown
| Non-Equity Incentive Plan | $905,370 |
|---|---|
| Option Awards | $2,069,998 |
| Salary | $690,000 |
| Stock Awards | $2,069,974 |
| Other | $4,540 |
| Total | $5,739,882 |
Sheridan received $2.1M in option awards, accounting for 36% of the total pay in 2021.
Sheridan also received $905.4K in non-equity incentive plan, $690K in salary, $2.1M in stock awards and $4.5K in other compensation.
Rankings
In 2021, John F. Sheridan's compensation ranked 2,212th out of 12,415 executives tracked by ExecPay. In other words, Sheridan earned more than 82.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,212 out of 12,415 | 82nd |
Division Manufacturing | 864 out of 5,505 | 84th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 90 out of 801 | 89th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 56 out of 522 | 89th |
Industry Surgical and Medical Instruments and Apparatus | 37 out of 327 | 89th |
Pay ratio
| John F. Sheridan's Pay | $5,739,882 |
|---|---|
| Median Employee's Pay | $75,196 |
| Pay Ratio | 76to 1 |
In 2021, the annual total compensation of John F. Sheridan was $5,739,882.
The annual total compensation of the median employee at Tandem Diabetes Care was $75,196.
The ratio of John F. Sheridan's pay to the pay of median employee was therefore 76 to one.
Sheridan's colleagues
We found five more compensation records of executives who worked with John F. Sheridan at Tandem Diabetes Care in 2021.
2021
Brian Hansen
Tandem Diabetes Care
Executive Vice President, Chief Commercial Officer
2021
David Berger
Tandem Diabetes Care
Chief Operating Officer
2021
Leigh Vosseller
Tandem Diabetes Care
Chief Financial Officer
2021
Elizabeth Gasser
Tandem Diabetes Care
Executive Vice President, Chief Strategy Officer
2021
Susan Morrison
Tandem Diabetes Care